[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614457":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":10,"responsibleParty":33,"collaborators":10,"id":35,"slug":10,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":10,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":10,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":10,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":10},{"fullName":5,"class":6},"Anhui Provincial Hospital","OTHER_GOV",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treat",null,[12],"Other: Observational",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","Observational","Long-term observational",[9],[20],{"name":21,"affiliation":22,"role":23},"Chaoshi Niu","The First Affiliated Hospital of University of Science and Technology of China","PRINCIPAL_INVESTIGATOR",[25,29],{"name":21,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","+86 13855186208","niuchaoshi@163.com",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Chi Xiong","+86 18709857411","xiongchi@ustc.edu.cn",{"type":34,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100614457",false,"NCT07279844","An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease","Inclusion Criteria:\n\n1. Subjects who have previously participated in RGL-193-related studies and have received RGL-193 treatment；\n2. Those who voluntarily participate in this trial and sign a written informed consent form -\n\nExclusion Criteria:\n\nNone\n\n\\-","ALL","45 Years","70 Years",{"count":44,"type":45},6,"ESTIMATED","OBSERVATIONAL","To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years",[49],"Parkinson's Disease","NOT_YET_RECRUITING","2025-12-01",{"date":53,"type":54},"2025-12-12","ACTUAL",{"date":56,"type":45},"2025-12-15",{"date":58,"type":45},"2029-12-14",{"name":5,"class":6}]